Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
Neuropharmacology
|
November 28, 2018
Pharmacological classification of centrally acting drugs using EEG in freely moving rats: an old tool to identify new atypical dopamine uptake inhibitors
Claudio Zanettini, Alessandro Scaglione, Jacqueline D Keighron, et al.
Frontiers in Neuroscience
|
June 14, 2021
Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
Melinda Hersey, Amanda K Bacon, Lydia G Bailey, et al.
Biomolecules
|
April 30, 2021
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor
Pramisha Adhikari, Bing Xie, Ana Semeano, et al.
Annals of Neurology
|
November 25, 2017
Targeting hypersensitive corticostriatal terminals in restless legs syndrome
Gabriel Yepes, Xavier Guitart, William Rea, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 19, 2005
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior
Gregory T Collins, Jeffrey M Witkin, Amy H Newman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 24, 2011
Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors
Takato Hiranita, Paul L Soto, Stephen J Kohut, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 27, 2007
Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats
Gianluigi Tanda, Aaron L Ebbs, Theresa A Kopajtic, et al.
Psychopharmacology
|
July 15, 2010
Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists
Ji-Kyung Choi, Joseph B Mandeville, Y Iris Chen, et al.
Journal of Medicinal Chemistry
|
June 14, 2002
Synthesis and evaluation of a novel series of 2-chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors
LaVerne L Brown, Santosh Kulkarni, Olga A Pavlova, et al.
Psychopharmacology
|
November 7, 2007
The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats
Krista Spiller, Zheng-Xiong Xi, Xiao-Qing Peng, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
Neuropharmacology
|
November 28, 2018
Pharmacological classification of centrally acting drugs using EEG in freely moving rats: an old tool to identify new atypical dopamine uptake inhibitors
Claudio Zanettini, Alessandro Scaglione, Jacqueline D Keighron, et al.
Frontiers in Neuroscience
|
June 14, 2021
Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
Melinda Hersey, Amanda K Bacon, Lydia G Bailey, et al.
Biomolecules
|
April 30, 2021
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor
Pramisha Adhikari, Bing Xie, Ana Semeano, et al.
Annals of Neurology
|
November 25, 2017
Targeting hypersensitive corticostriatal terminals in restless legs syndrome
Gabriel Yepes, Xavier Guitart, William Rea, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 19, 2005
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior
Gregory T Collins, Jeffrey M Witkin, Amy H Newman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 24, 2011
Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors
Takato Hiranita, Paul L Soto, Stephen J Kohut, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 27, 2007
Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats
Gianluigi Tanda, Aaron L Ebbs, Theresa A Kopajtic, et al.
Psychopharmacology
|
July 15, 2010
Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists
Ji-Kyung Choi, Joseph B Mandeville, Y Iris Chen, et al.
Journal of Medicinal Chemistry
|
June 14, 2002
Synthesis and evaluation of a novel series of 2-chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors
LaVerne L Brown, Santosh Kulkarni, Olga A Pavlova, et al.
Psychopharmacology
|
November 7, 2007
The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats
Krista Spiller, Zheng-Xiong Xi, Xiao-Qing Peng, et al.
Page
of 8